http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108126011-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108126011-B |
titleOfInvention | Pharmaceutical composition for auxiliary conditioning of patients undergoing tumor radiotherapy and chemotherapy and preparation method thereof |
abstract | The invention belongs to the field of medicines or health-care products, and particularly relates to a composition for assisting in conditioning patients undergoing tumor radiotherapy and chemotherapy and a preparation method thereof. The invention aims to provide a brand new composition for tonifying body and strengthening body resistance, particularly for assisting in conditioning patients suffering from tumor chemotherapy and radiotherapy and for assisting in protecting radiation hazards. The composition of the invention takes cordyceps sinensis, wall-broken ganoderma lucidum spore powder, angelica sinensis, astragalus membranaceus, cinnamon and liquorice as raw material medicines, and the weight ratio is as follows: 1-8 parts of cordyceps sinensis, 5-30 parts of wall-broken ganoderma lucidum spore powder, 3-25 parts of angelica sinensis, 10-80 parts of astragalus membranaceus, 3-25 parts of cinnamon and 10-60 parts of liquorice. Compared with the similar products on the market, the invention has the advantages of clear effect, stable curative effect and controllability, and provides a brand new choice for the public. |
priorityDate | 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.